Infinisource Benefit Services will be on display with its innovative benefits administration products at the upcoming Coastal Empire Association of Health Underwriters Symposium & Exhibitor Fair. The event will take place at The Hyatt Regency Savannah in Savannah, Georgia on April 25. The 14th annual occurrence of this event offers health insurance professionals in Georgia with the opportunity to participate in continuing education, receive updates on the industry, and meet carrier partners. [Read more…]

The National Council on Compensation Insurance (NCCI) is examining the growing issues related to opioid use in America through a three-part series, On Opioids. This series is aimed at exploring three viewpoints on issues surrounding opioid use and workers compensation: those of doctors, insurers, and regulators. NCCI has posted its first article of the series—On Opioids: The Doctors’ Perspectives—on ncci.com. [Read more…]

Florida Blue, a leading health insurer in Florida, has partnered with Welltok, a leading enterprise Software as a Service company for consumer health. The partnership provides Florida Blue members with access to a unique digital health and wellbeing program designed to help individuals become and stay healthy. [Read more…]

Avella will distribute naloxone, a powerful therapy used to treat opioid overdoses, as part of an innovative new program designed to improve access to the drug. The program allows individuals and family members in certain states to simply contact the pharmacy and order the drug by phone, with no physician prescription needed. In these circumstances, one of Avella’s pharmacists will actually supply the prescription if they determine that EVZIO® (naloxone HCl injection) or another naloxone therapy is appropriate. [Read more…]

One quarter (25%) of U.S. employees surveyed have worked with an executive who became severely ill and whose illness affected the company. This finding of the HealthMine 2018 Rising Risk Survey highlights the need for companies to do a better job of identifying key employees who are at-risk for a chronic illness. Once risks are identified, plan members can engage in personalized health actions to help ward off disease. In addition, companies can implement contingency and succession plans should these employees suddenly become sick. [Read more…]

The healthcare industry has been slow to adopt new technologies, including the cloud. However, industry-wide demand to use health data to improve system efficiency, deliver value-based care and enable productive collaborations is driving investment in cloud solutions. [Read more…]

Change Healthcare and Zebra Medical Vision today announced an agreement to create solutions that deliver artificial intelligence solutions to complex radiology reporting environments. Change Healthcare’s proven radiology solutions, along with Zebra Medical Vision’s algorithms, will benefit radiologists and other imaging specialists by improving the efficiency of routine tasks and the effectiveness of workflow in the radiologist reading environment. [Read more…]

Deloitte, a leader in life sciences and health care consulting services, announced today that it has achieved Amazon Web Services (AWS) Life Sciences Competency status. This designation recognizes Deloitte for its ability to build successful life sciences solutions on AWS to help customers conduct drug discovery, manage clinical trials, engage in manufacturing and distribution activities, and conduct research and development of novel genetic-based treatments and companion diagnostics. [Read more…]

Majorly, chronic myelogenous leukemia (CML) occurs in adults, however, it sometimes occurs in children as well. However, targeted drugs called Tyrosine-Kinase Inhibitors (TKIs) have been effective in providing long-term survival rates. Meanwhile, the Food and Drug Administration (FDA) has recently approved dasatinib (Sprycel) for the treatment of chronic myelogenous leukemia in children. As the chronic myeloid leukemia is more aggressive in younger patients, the approval of drugs can help in effective treatment. [Read more…]

MyDx, Inc. (OTC: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments it alleviates, today announced it filed patents on its revolutionary, second smart device — The ECOSmartPenTM — and is now accepting Pre-Orders. [Read more…]